Horizon looking brighter again for UK science

7 September 2023
brexit_uk_europe_horizon_large

After years of uncertainty stemming from the UK’s departure from the European Union (EU), Prime Minister Rishi Sunak has confirmed that, from Thursday onwards, British scientists can apply once again for grants from the £85 billion ($106 billion) H|orizon program.

Horizon Europe is the EU’s framework program for research and innovation, the largest of its kind in the world. UK participation in its predecessor Horizon 2020 and earlier programs was guaranteed by the UK’s membership of the EU, which ended in early 2020.

"This restores faith in the UK’s desire to be one of the global superpowers in life sciences"Many companies on both sides of the Channel have felt the impact of the lack of funding and international cooperation during the period since.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical